At what price was Blair E. Hendrix’s Surgery Partners (SGRY) share award recorded?

The 11,670-share award to Blair E. Hendrix was recorded at $13.71 per share. This figure typically represents a grant or reference price used for the equity award, not necessarily a cash purchase price in the open market.

Blair Hendrix of Surgery Partners (SGRY) receives 11,670-share equity grant

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

HENDRIX BLAIR E reported acquisition or exercise transactions in this Form 4 filing.

Surgery Partners, Inc. director and ten percent owner Blair E. Hendrix received a grant of 11,670 shares of common stock on June 5, 2026 at a reference price of $13.71 per share. These shares will vest on June 5, 2027, indicating a time-based equity award rather than an immediate cash transaction.

After this award, Hendrix beneficially owns 18,531 shares of common stock directly. The filing also notes that shares previously reported as indirectly owned through Bain Capital Investors, LLC are no longer included in the total beneficially owned amount following this transaction, so the reported holdings now reflect only the direct position.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HENDRIX BLAIR E

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,670	$13.71	$160K

Holdings After Transaction: Common Stock — 18,531 shares (Direct, null)

Footnotes (1)

Shares will vest on June 5, 2027. Previously reported shares indirectly owned through Bain Capital Investors, LLC are no longer reflected in the amount of securities beneficially owned following reported transaction.

Key Figures

Share grant size: 11,670 shares Grant price: $13.71 per share Holdings after grant: 18,531 shares +1 more

4 metrics

Share grant size 11,670 shares Common stock award on June 5, 2026

Grant price $13.71 per share Reference price for equity award

Holdings after grant 18,531 shares Total beneficially owned directly after transaction

Vesting date June 5, 2027 Date when granted shares will vest

Key Terms

Grant, award, or other acquisition, beneficially owned, vest, ten percent owner

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

beneficially owned financial

"no longer reflected in the amount of securities beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

vest financial

"Shares will vest on June 5, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

ten percent owner financial

"reporting person is_ten_percent_owner: 1"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/09/2026 - 08:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HENDRIX BLAIR E

(Last)

(First)

(Middle)

200 CLARENDON STREET

(Street)

BOSTON

MASSACHUSETTS

02116

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Surgery Partners, Inc. [ SGRY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/05/2026		A		11,670⁽¹⁾	A	$13.71	18,531⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares will vest on June 5, 2027.

2. Previously reported shares indirectly owned through Bain Capital Investors, LLC are no longer reflected in the amount of securities beneficially owned following reported transaction.

Remarks:

	/s/ Blair E. Hendrix	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Surgery Partners (SGRY) report for Blair E. Hendrix?

Surgery Partners reported that director and ten percent owner Blair E. Hendrix received a grant of 11,670 shares of common stock. The award was recorded at $13.71 per share and increased his directly beneficially owned holdings to 18,531 shares after the transaction.

When will Blair E. Hendrix’s new Surgery Partners (SGRY) shares vest?

The shares granted to Blair E. Hendrix will vest on June 5, 2027. Until vesting, the award is subject to the vesting conditions described, meaning Hendrix does not have fully vested rights to these shares before that date.

How many Surgery Partners (SGRY) shares does Blair E. Hendrix own after this transaction?

Following the equity grant, Blair E. Hendrix beneficially owns 18,531 shares of Surgery Partners common stock directly. The filing clarifies that previously reported shares indirectly owned through Bain Capital Investors, LLC are no longer included in this beneficial ownership total.

What changed regarding Blair E. Hendrix’s indirect Surgery Partners (SGRY) holdings?

The filing states that shares previously reported as indirectly owned through Bain Capital Investors, LLC are no longer reflected in Blair E. Hendrix’s beneficially owned total. As a result, the reported 18,531 shares now represent only his directly held position.